Abstract CT256: A pilot clinical study of VAL-413 (Orotecan®, oral irinotecan HCl) in patients with recurrent pediatric solid tumors

Intravenous irinotecan hydrochloride (IRN-IV) is approved for the treatment of adult colorectal cancer. IRN-IV is also widely used off-label for a range of adult and pediatric solid tumors including recurrent Ewing sarcoma, rhabdomyosarcoma, neuroblastoma, hepatoblastoma, Wilms tumor, gynecologic ca...

Full description

Bibliographic Details

Published in:	Cancer research (Chicago, Ill.) Vol. 82; no. 12_Supplement; p. CT256
Main Authors:	Geller, James, Thompson, Patrick, Oesterheld, Javier, Brown, Dennis M., Bacha, Jeffrey, Kanekal, Sarath, Lopez, Lorena, Leggas, Markos, Sankar, Neil, Yam, Noymi, Wagner, Lars M.
Format:	Journal Article
Language:	English
Published:	15-06-2022
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!